Literature DB >> 846404

Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: augmentation by thyroid hormone.

M Maebashi, N Kawamura, M Sato, A Imamura, K Yoshinaga.   

Abstract

Urinary excretion of carnitine and serum concentrations of carnitine, triglyceride, and free fatty acids were measured in 54 hyperthyroid and 13 hypothyroid patients, and the results were compared with those of normal subjects. In hyperthyroid patients urinary excretion of carnitine was highly increased above that of the control subjects. On adequate treatment with antithyroid drug, carnitine excretion was reduced to the normal range, and serum lipids changed in parallel. In contrast, carnitine excretion was markedly reduced in hypothyroid patients. After substitution therapy with thyroid hormones the excretion increased in these patients. This change was associated with a marked reduction of serum triglyceride. There was an inverse correlation between urinary excretion of carnitine and serum triglyceride concentration. Carnitine excretion was significantly correlated with serum thyroxine concentration in hyper- and hypothyroid patients. The results suggest that thyroid hormones play an important role in carnitine metabolism, which in turn influences serum triglyceride metabolism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 846404     DOI: 10.1016/0026-0495(77)90101-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Relationship between acid-soluble carnitine and coenzyme A pools in vivo.

Authors:  E P Brass; C L Hoppel
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

2.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

3.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

4.  Myopathy in Williams-Beuren syndrome.

Authors:  T Voit; H Kramer; C Thomas; W Wechsler; H Reichmann; H G Lenard
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

5.  Non-diabetic ketoacidosis secondary to primary hyperthyroidism: A case report.

Authors:  Abdulrahman F Al-Mashdali; Mohammadshah Gul; Waseem Umer; Abeer Omar; Akhnuwkh Jones
Journal:  Medicine (Baltimore)       Date:  2022-06-10       Impact factor: 1.817

Review 6.  Nutraceutical Supplements in the Thyroid Setting: Health Benefits beyond Basic Nutrition.

Authors:  Salvatore Benvenga; Ulla Feldt-Rasmussen; Daniela Bonofiglio; Ernest Asamoah
Journal:  Nutrients       Date:  2019-09-13       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.